← Leaderboards
Courtney C Aldrich
University Of Minnesota
$9,602,262
Attributed
$13,706,335
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,706,335 · 10
By mechanism
R01$12,513,352 · 4
R21$1,016,990 · 3
S10$93,625 · 1
R03$74,368 · 1
R13$8,000 · 1
Top collaborators
- Veronique Dartois5 shared
- Dirk Schnappinger5 shared
- Thomas Dick3 shared
- Anthony D Baughn2 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Dirk Schnappinger$17,202,306
- Veronique Dartois$28,450,941
Others in their field
Top investigators on “Tuberculosis”
- Judith S. Currier · University Of California Los Angeles$301,722,065
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$297,204,160
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$267,912,117
- Lawrence Corey · Fred Hutchinson Cancer Center$255,939,398
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$200,192,298
- Sharon A Nachman · Johns Hopkins University$194,852,226
Research focus
TuberculosisEnzymesMycobacterium TuberculosisPathogenCommunicable DiseasesIn VivoPharmaceutical PreparationsLeadAnabolismDesignAnalogProgramsAntitubercular AgentsTuberculosis DrugsResistanceCellsAids-Related Opportunistic InfectionsDrug KineticsAtypical MycobacteriaInhibitor/AntagonistBiochemicalPharmaceutical ChemistryMouse ModelMutant
Grant awards (30)
Optimization of rifamycins to overcome intrinsic resistance of nontuberculous mycobacteria to improve treatment of NTM lung disease$838,280
R01 · FY2025 · AI
Optimization of rifamycins to overcome intrinsic resistance of nontuberculous mycobacteria to improve treatment of NTM lung disease$838,280
R01 · FY2024 · AI
Optimization of rifamycins to overcome intrinsic resistance of nontuberculous mycobacteria to improve treatment of NTM lung disease$857,555
R01 · FY2023 · AI
Targeting Biotin Metabolism in Mycobacterium Tuberculosis$779,863
R01 · FY2023 · AI · contact PI
Targeting Biotin Metabolism in Mycobacterium Tuberculosis$779,863
R01 · FY2022 · AI · contact PI
Siderophore Inhibitors for Tuberculosis that Block Mycobactin Biosynthesis$745,441
R01 · FY2022 · AI · contact PI
Targeting Biotin Metabolism in Mycobacterium Tuberculosis$779,863
R01 · FY2021 · AI · contact PI
Siderophore Inhibitors for Tuberculosis that Block Mycobactin Biosynthesis$754,075
R01 · FY2021 · AI · contact PI
Overcoming Pyrazinamide Resistance with Pyrazinoate-Cephalosporin Conjugates$191,744
R21 · FY2021 · AI · contact PI
Targeting Biotin Metabolism in Mycobacterium Tuberculosis$779,863
R01 · FY2020 · AI · contact PI
Siderophore Inhibitors for Tuberculosis that Block Mycobactin Biosynthesis$761,214
R01 · FY2020 · AI · contact PI
Overcoming Pyrazinamide Resistance with Pyrazinoate-Cephalosporin Conjugates$229,632
R21 · FY2020 · AI · contact PI
Targeting Biotin Metabolism in Mycobacterium Tuberculosis$820,039
R01 · FY2019 · AI · contact PI
Siderophore Inhibitors for Tuberculosis that Block Mycobactin Biosynthesis$770,507
R01 · FY2019 · AI · contact PI
Siderophore Inhibitors for Tuberculosis that Block Mycobactin Biosynthesis$805,741
R01 · FY2018 · AI · contact PI
2017 Tuberculosis Drug Discovery and Development Gordon Research Conference and Gordon Research Seminar$8,000
R13 · FY2017 · AI · contact PI
iTC200 MicroCalorimetry Cell Control Unit$93,625
S10 · FY2014 · OD · contact PI
Design of Antituberculosis Agents that Target Siderophore Biosynthesis$316,171
R01 · FY2013 · AI · contact PI
A Fluorescence Displacement Assay for the Biotin Biosynthetic Enzyme BioA$36,618
R03 · FY2013 · MH · contact PI
Design of Antituberculosis Agents that Target Siderophore Biosynthesis$336,353
R01 · FY2012 · AI · contact PI
A Fluorescence Polarization Assay for Fatty Acid Adenylating Enzymes$37,750
R21 · FY2012 · NS · contact PI
A fluorescence displacement assay for BioA: An enzyme involved in biotin biosynth$37,750
R03 · FY2012 · MH · contact PI
Design of Antituberculosis Agents that Target Siderophore Biosynthesis$336,353
R01 · FY2011 · AI · contact PI
Design of Antituberculosis Agents that Target Siderophore Biosynthesis$339,750
R01 · FY2010 · AI · contact PI
A Fluorescence Polarization Assay for Fatty Acid Adenylating Enzymes$151,000
R21 · FY2009 · NS · contact PI
Design of antituberculosis agents that target siderophore biosynthesis$284,812
R01 · FY2008 · AI · contact PI
Thioesterase Inhibitors of Mycolic Acid Biosynthesis as Antitubercular Agents$219,989
R21 · FY2008 · AI · contact PI
Design of antituberculosis agents that target siderophore biosynthesis$290,329
R01 · FY2007 · AI · contact PI
Thioesterase Inhibitors of Mycolic Acid Biosynthesis as Antitubercular Agents$186,875
R21 · FY2007 · AI · contact PI
Design of antituberculosis agents that target siderophore biosynthesis$299,000
R01 · FY2006 · AI · contact PI